Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors
Medable Inc., the leading cloud platform for patient-centered drug development, today announced results from a […]
Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures, and Tiger Global
Medable Inc., the leading cloud platform for patient-centered clinical research, today announced $304 million in Series […]
Medable Hires Chief Strategy Officer to Expand Global Partner and Innovation Ecosystem for Decentralized Clinical Trials
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the hiring of Dr. […]
Medable Opens New EMEA Headquarters in Dublin; Expands European Presence to Grow Market for Decentralized Clinical Trials
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the first stage […]
Medable Launches Digital Certification Program to Accelerate Adoption of Decentralized Clinical Trials
Medable Inc., the leading software platform for patient-centered drug development, today announced an industry-first digital certification […]
Medable Hires Sanskriti Thakur as Chief Growth Officer to Lead Market Expansion
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the hiring of Sanskriti […]
Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development
Medable Inc. today announced $78 million in new funding to fuel advances in the delivery […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more